这是一篇来自已证抗体库的有关人类 CD62L的综述,是根据122篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD62L 抗体。
CD62L 同义词: CD62L; LAM1; LECAM1; LEU8; LNHR; LSEL; LYAM1; PLNHR; TQ1

其他
  • 流式细胞仪; 人类; 图 3a
CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3a). Cell Stem Cell (2019) ncbi
CD62L抗体(BioLegend, DREG-56)被用于. J Clin Invest (2018) ncbi
CD62L抗体(BioLegend, 304812)被用于. J Cell Sci (2018) ncbi
赛默飞世尔
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 3c
赛默飞世尔 CD62L抗体(eBiosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3c). Oncoimmunology (2017) ncbi
小鼠 单克隆(DREG56)
  • 免疫印迹; 人类; 图 3d
赛默飞世尔 CD62L抗体(Thermo Fischer Scientific, MA1-10259)被用于被用于免疫印迹在人类样本上 (图 3d). Toxicol In Vitro (2017) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD62L抗体(Thermo Fisher Scientific, 17-0629)被用于被用于流式细胞仪在人类样本上 (图 s1). Cell Res (2017) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s2). Oncoimmunology (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s2
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s2). Oncoimmunology (2017) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(ebioscience, DREG-56)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 s5c
赛默飞世尔 CD62L抗体(eBiosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s5c). PLoS Pathog (2016) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 2c
赛默飞世尔 CD62L抗体(eBioscience, 47-0629-42)被用于被用于流式细胞仪在人类样本上 (图 2c). J Clin Invest (2017) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Invitrogen, Dreg 56)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2016) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 1h
赛默飞世尔 CD62L抗体(eBiosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1h). J Clin Invest (2016) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔 CD62L抗体(eBiosciences, 48-0629)被用于被用于流式细胞仪在人类样本上 (图 5a). Eur J Immunol (2016) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD62L抗体(eBioscience, Dreg-56)被用于被用于流式细胞仪在人类样本上 (图 s1). Vaccine (2016) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 1c
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1c). Br J Cancer (2016) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD62L抗体(Invitrogen, Dreg-56)被用于被用于流式细胞仪在人类样本上 (图 2). Arch Med Res (2015) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 e4a
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 e4a). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2.b,c
赛默飞世尔 CD62L抗体(eBioscience, MHCD62L04)被用于被用于流式细胞仪在人类样本上 (图 2.b,c). Nature (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2.b,c
赛默飞世尔 CD62L抗体(eBioscience, MHCD62L04)被用于被用于流式细胞仪在人类样本上 (图 2.b,c). Vaccine (2015) ncbi
小鼠 单克隆(DREG56)
  • 免疫组化; 人类; 1:100
  • 免疫印迹; 人类; 1:500
赛默飞世尔 CD62L抗体(eBioscience, DEG56)被用于被用于免疫组化在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:500. J Virol (2015) ncbi
小鼠 单克隆(LT-TD180)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Thermo, LT-TD180)被用于被用于流式细胞仪在人类样本上. J Virol (2015) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 免疫组化; 人类; 1:100
  • 免疫印迹; 人类; 1:500
赛默飞世尔 CD62L抗体(eBioscience, DEG56)被用于被用于免疫组化在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:500. J Virol (2015) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD62L抗体(eBioscience, DREG56)被用于被用于流式细胞仪在人类样本上 (图 s3). Infect Immun (2015) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s1). Cancer Immunol Res (2015) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, Dreg-56)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Invitrogen, Dreg-56)被用于被用于流式细胞仪在人类样本上. Leukemia (2015) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD62L抗体(eBioscience, DREG56)被用于被用于流式细胞仪在人类样本上 (图 s1). PLoS Pathog (2011) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在小鼠样本上 (图 3). Blood (2010) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD62L抗体(Caltag, Dreg-56)被用于被用于流式细胞仪在人类样本上 (图 1). Clin Immunol (2010) ncbi
小鼠 单克隆(DREG56)
  • 免疫组化-冰冻切片; 人类; 图 2
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于免疫组化-冰冻切片在人类样本上 (图 2). Dev Biol (2006) ncbi
小鼠 单克隆(DREG56)
  • 免疫组化-石蜡切片; 人类; 图 1
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Reprod Toxicol (2006) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (表 2). Eur J Immunol (2005) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 表 2
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (表 2). Eur J Immunol (2005) ncbi
小鼠 单克隆(DREG-56 (DREG56))
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(eBioscience, DREG-56)被用于被用于流式细胞仪在人类样本上. Blood (2005) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2005) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2005) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3). J Immunol (2004) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (表 1). Atherosclerosis (2004) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 7c
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 7c). J Biomed Mater Res A (2003) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 7c
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 7c). J Biomed Mater Res A (2003) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. Cytometry B Clin Cytom (2003) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. J Hematother Stem Cell Res (2003) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. J Hematother Stem Cell Res (2003) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. J Virol (2002) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD62L抗体(Caltag Laboratories, clone DREG-56)被用于被用于流式细胞仪在人类样本上 (图 2). Blood (2002) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 2). Blood (2000) ncbi
小鼠 单克隆(DREG56)
  • 抑制或激活实验; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于抑制或激活实验在人类样本上. Blood (2000) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
赛默飞世尔 CD62L抗体(Caltag, DREG-56)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (1999) ncbi
BioLegend
小鼠 单克隆(DREG-56)
  • mass cytometry; 人类; 图 2d
BioLegend CD62L抗体(Biolegend, 304835)被用于被用于mass cytometry在人类样本上 (图 2d). Biomark Res (2022) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s4e
BioLegend CD62L抗体(Biolenged, 304835)被用于被用于流式细胞仪在人类样本上 (图 s4e). Science (2021) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1c
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1c). EMBO Mol Med (2021) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s7b
BioLegend CD62L抗体(Biolegend, 304822)被用于被用于流式细胞仪在人类样本上 (图 s7b). Nat Commun (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3a). Cell Stem Cell (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s2b
BioLegend CD62L抗体(Biolegend, 304833)被用于被用于流式细胞仪在人类样本上 (图 s2b). Cell (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s3
BioLegend CD62L抗体(Biolegend, 304805)被用于被用于流式细胞仪在人类样本上 (图 s3). Leukemia (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD62L抗体(BioLegend, 304822)被用于被用于流式细胞仪在人类样本上 (图 2a). Cell Rep (2018) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s1
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s1). J Clin Invest (2018) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 7
BioLegend CD62L抗体(biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 7). J Immunol (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2
BioLegend CD62L抗体(BioLegend, 304,821)被用于被用于流式细胞仪在人类样本上 (图 2). Immun Ageing (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1a
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1a). J Virol (2017) ncbi
小鼠 单克隆(DREG-56)
  • mass cytometry; 人类; 图 s3a
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于mass cytometry在人类样本上 (图 s3a). Science (2017) ncbi
小鼠 单克隆(DREG-56)
  • mass cytometry; 人类; 图 s8
BioLegend CD62L抗体(BioLegend, 304802)被用于被用于mass cytometry在人类样本上 (图 s8). Nature (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2f
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 2f). Am J Transplant (2017) ncbi
小鼠 单克隆(DREG-56)
  • 免疫细胞化学; 人类; 图 s3c
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于免疫细胞化学在人类样本上 (图 s3c). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3e
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3e). Sci Rep (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3a
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS ONE (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 表 1
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s9
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s9). Am J Transplant (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s7
BioLegend CD62L抗体(BioLegend, 304813)被用于被用于流式细胞仪在人类样本上 (图 s7). Nat Biotechnol (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 4a
BioLegend CD62L抗体(biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上. Kidney Int (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 4
BioLegend CD62L抗体(Biolegend, 304809)被用于被用于流式细胞仪在人类样本上 (图 4). J Neuroinflammation (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, 304810)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2015) ncbi
小鼠 单克隆(DREG-56)
BioLegend CD62L抗体(Biolegend, 304822)被用于. Cancer Res (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2f
BioLegend CD62L抗体(BioLegend, DREG56)被用于被用于流式细胞仪在人类样本上 (图 2f). Blood (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, Dreg56)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上. Med Microbiol Immunol (2014) ncbi
小鼠 单克隆(DREG-56)
BioLegend CD62L抗体(Biolegend, 304822)被用于. PLoS ONE (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 1 ug/ml
BioLegend CD62L抗体(BioLegend, DREG-56)被用于被用于流式细胞仪在人类样本上浓度为1 ug/ml. Sci Rep (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
BioLegend CD62L抗体(Biolegend, DREG-56)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(B-8)
  • 流式细胞仪; 人类; 图 3d
圣克鲁斯生物技术 CD62L抗体(Santa Cruz Biotechnology, sc-390756)被用于被用于流式细胞仪在人类样本上 (图 3d). Diabetes (2020) ncbi
小鼠 单克隆(LAM1-116)
  • 免疫组化; 人类; 1:250
圣克鲁斯生物技术 CD62L抗体(Santa, Lam1-116)被用于被用于免疫组化在人类样本上浓度为1:250. J Virol (2015) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 1
圣克鲁斯生物技术 CD62L抗体(Santa Cruz Biotechnology, sc-18851)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2014) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD62L抗体(Beckman Coulter, IM2713U)被用于被用于流式细胞仪在人类样本上. J Clin Invest (2020) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 1a
贝克曼库尔特实验系统(苏州)有限公司 CD62L抗体(Beckman Coulter, DREG56)被用于被用于流式细胞仪在人类样本上 (图 1a). Int J Cancer (2017) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 表 3
贝克曼库尔特实验系统(苏州)有限公司 CD62L抗体(Beckman Coulter (Immunotech), Dreg 56)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi
小鼠 单克隆(DREG56)
  • 流式细胞仪; 人类; 图 1
贝克曼库尔特实验系统(苏州)有限公司 CD62L抗体(IOTest, IM1231U)被用于被用于流式细胞仪在人类样本上 (图 1). Cytometry B Clin Cytom (2018) ncbi
EuroBioSciences
小鼠 单克隆(LT-TD180)
  • 流式细胞仪; 人类; 图 4b
EuroBioSciences CD62L抗体(EuroBiosciences, LT-TD180)被用于被用于流式细胞仪在人类样本上 (图 4b). J Clin Invest (2017) ncbi
碧迪BD
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3f
碧迪BD CD62L抗体(BD Bioscience, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 3f). J Immunother Cancer (2021) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 小鼠; 1:1000
碧迪BD CD62L抗体(BD Biosciences, 559772)被用于被用于流式细胞仪在小鼠样本上浓度为1:1000. Cell Rep Med (2021) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD62L抗体(BD, 555543)被用于被用于流式细胞仪在人类样本上 (图 3a). Signal Transduct Target Ther (2021) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD62L抗体(BD, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1c). EMBO Mol Med (2021) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CD62L抗体(BD, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1c). Nature (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 1:12.5; 图 6c
碧迪BD CD62L抗体(BD Biosciences, 561916)被用于被用于流式细胞仪在人类样本上浓度为1:12.5 (图 6c). Nat Commun (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD62L抗体(BD Biosciences, 555544)被用于被用于流式细胞仪在人类样本上 (图 5a). BMC Immunol (2019) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s5a
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s5a). Proc Natl Acad Sci U S A (2018) ncbi
小鼠 单克隆(SK11)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD62L抗体(BD Biosciences, SK11)被用于被用于流式细胞仪在人类样本上 (图 2a). J Clin Invest (2018) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 2a). Nat Med (2018) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CD62L抗体(BD Biosciences, 555543)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncotarget (2018) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 st12
碧迪BD CD62L抗体(BD, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 st12). Science (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CD62L抗体(BD, 555543)被用于被用于流式细胞仪在人类样本上 (图 3d). Cell (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s1g
碧迪BD CD62L抗体(BD Bioscience, Dreg-56)被用于被用于流式细胞仪在人类样本上 (图 s1g). Immunity (2017) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 4a
碧迪BD CD62L抗体(BD, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 4a). PLoS ONE (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 表 3
碧迪BD CD62L抗体(BD Pharmingen, DREG-56)被用于被用于流式细胞仪在人类样本上 (表 3). Brain Behav (2016) ncbi
小鼠 单克隆(SK11)
  • 流式细胞仪; 人类; 图 3c
碧迪BD CD62L抗体(BD Biosciences, SK11)被用于被用于流式细胞仪在人类样本上 (图 3c). Oncotarget (2016) ncbi
小鼠 单克隆(SK11)
  • 流式细胞仪; 人类; 图 s3
碧迪BD CD62L抗体(BD, 341012)被用于被用于流式细胞仪在人类样本上 (图 s3). PLoS Pathog (2016) ncbi
小鼠 单克隆(SK11)
  • 流式细胞仪; 人类; 图 st9
碧迪BD CD62L抗体(BD Biosciences, SK11)被用于被用于流式细胞仪在人类样本上 (图 st9). JCI Insight (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s2e
碧迪BD CD62L抗体(BD, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s2e). J Clin Invest (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 小鼠; 图 st1
碧迪BD CD62L抗体(BD Pharmingen, DREG-56)被用于被用于流式细胞仪在小鼠样本上 (图 st1). J Clin Invest (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 5c
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 5c). J Immunol (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Pharmingen, DREG-56)被用于被用于流式细胞仪在人类样本上. J Leukoc Biol (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 1:100; 图 s6b
碧迪BD CD62L抗体(BD Biosciences, DREG56)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 s6b). Nat Commun (2016) ncbi
小鼠 单克隆(DREG-56)
  • 其他; 人类; 500 ug/ml; 图 2
碧迪BD CD62L抗体(Becton Dickinson, 555542)被用于被用于其他在人类样本上浓度为500 ug/ml (图 2). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(SK11)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD62L抗体(BD, 341012)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD62L抗体(BD Pharmingen, Dreg56)被用于被用于流式细胞仪在人类样本上 (图 5a). PLoS ONE (2016) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 1
碧迪BD CD62L抗体(BD Bioscience, DREG56)被用于被用于流式细胞仪在人类样本上 (图 1). Nat Immunol (2016) ncbi
小鼠 单克隆(SK11)
  • 流式细胞仪; 猕猴; 图 4
碧迪BD CD62L抗体(BD Biosciences, Sk11)被用于被用于流式细胞仪在猕猴样本上 (图 4). J Virol (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Biosciences, clone DREG-56)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 s1). PLoS ONE (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上 (图 2). J Autoimmun (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Biosciences, Dreg56)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Bioscience, DREG-56)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(Becton-Dickinson, Dreg-56)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Pharmigen, DREG56)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(DREG-56)
  • 流式细胞仪; 人类
碧迪BD CD62L抗体(BD Biosciences, DREG-56)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
文章列表
  1. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed 出版商
  2. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed 出版商
  3. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed 出版商
  4. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed 出版商
  5. Mo F, Duan S, Jiang X, Yang X, Hou X, Shi W, et al. Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy. Signal Transduct Target Ther. 2021;6:80 pubmed 出版商
  6. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed 出版商
  7. Liu C, Teo M, Pek S, Wu X, Leong M, Tay H, et al. A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions. Diabetes. 2020;69:2467-2480 pubmed 出版商
  8. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed 出版商
  9. Lynn R, Weber E, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293-300 pubmed 出版商
  10. Götzke H, Kilisch M, Martínez Carranza M, Sograte Idrissi S, Rajavel A, Schlichthaerle T, et al. The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat Commun. 2019;10:4403 pubmed 出版商
  11. Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun. 2019;10:4109 pubmed 出版商
  12. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed 出版商
  13. Dagur R, Branch Woods A, Mathews S, Joshi P, Quadros R, Harms D, et al. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 2019;20:2 pubmed 出版商
  14. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed 出版商
  15. Velázquez Avila M, Balandrán J, Ramírez Ramírez D, Velázquez Avila M, Sandoval A, Felipe López A, et al. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse. Leukemia. 2019;33:1337-1348 pubmed 出版商
  16. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed 出版商
  17. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed 出版商
  18. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed 出版商
  19. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed 出版商
  20. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed 出版商
  21. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed 出版商
  22. Buffone A, Anderson N, Hammer D. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. J Cell Sci. 2018;131: pubmed 出版商
  23. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed 出版商
  24. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  25. Krogh Nielsen M, Hector S, Allen K, Subhi Y, Sørensen T. Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration. Immun Ageing. 2017;14:18 pubmed 出版商
  26. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed 出版商
  27. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed 出版商
  28. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  29. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed 出版商
  30. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed 出版商
  31. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed 出版商
  32. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed 出版商
  33. Millrud C, Kågedal A, Kumlien Georén S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140:2557-2567 pubmed 出版商
  34. Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, et al. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell. 2017;168:789-800.e10 pubmed 出版商
  35. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed 出版商
  36. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed 出版商
  37. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed 出版商
  38. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed 出版商
  39. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  40. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed 出版商
  41. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed 出版商
  42. Rathod K, Kapil V, Velmurugan S, Khambata R, Siddique U, Khan S, et al. Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans. J Clin Invest. 2017;127:169-182 pubmed 出版商
  43. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  44. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed 出版商
  45. Miles B, Miller S, Folkvord J, Levy D, Rakasz E, Skinner P, et al. Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection. PLoS Pathog. 2016;12:e1005924 pubmed 出版商
  46. Jung Y, Riven I, Feigelson S, Kartvelishvily E, Tohya K, Miyasaka M, et al. Three-dimensional localization of T-cell receptors in relation to microvilli using a combination of superresolution microscopies. Proc Natl Acad Sci U S A. 2016;113:E5916-E5924 pubmed
  47. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed 出版商
  48. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed 出版商
  49. Fuchs S, Kaiser Labusch P, Bank J, Ammann S, Kolb Kokocinski A, Edelbusch C, et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46:2639-2649 pubmed 出版商
  50. Ferre E, Rose S, Rosenzweig S, Burbelo P, Romito K, Niemela J, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;1: pubmed
  51. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed 出版商
  52. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed 出版商
  53. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed 出版商
  54. Wonner R, Wallner S, Orso E, Schmitz G. Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry B Clin Cytom. 2018;94:596-605 pubmed 出版商
  55. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed 出版商
  56. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  57. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  58. Sommer A, Kordowski F, Büch J, Maretzky T, Evers A, Andrä J, et al. Phosphatidylserine exposure is required for ADAM17 sheddase function. Nat Commun. 2016;7:11523 pubmed 出版商
  59. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed 出版商
  60. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  61. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  62. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed 出版商
  63. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  64. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  65. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippé J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Br J Cancer. 2016;114:704-12 pubmed 出版商
  66. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed 出版商
  67. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  68. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed 出版商
  69. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  70. Arriaga Pizano L, Ferat Osorio E, Rodríguez Abrego G, Mancilla Herrera I, Domínguez Cerezo E, Valero Pacheco N, et al. Differential Immune Profiles in Two Pandemic Influenza A(H1N1)pdm09 Virus Waves at Pandemic Epicenter. Arch Med Res. 2015;46:651-8 pubmed 出版商
  71. Whisenant T, Peralta E, Aarreberg L, Gao N, Head S, Ordoukhanian P, et al. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. PLoS ONE. 2015;10:e0144409 pubmed 出版商
  72. Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L, et al. Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2016;17:95-103 pubmed 出版商
  73. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  74. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  75. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed 出版商
  76. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed 出版商
  77. Han J, Li E, Chen L, Zhang Y, Wei F, Liu J, et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature. 2015;524:243-6 pubmed 出版商
  78. Melgaço J, Morgado L, Santiago M, Oliveira J, Lewis Ximenez L, Hasselmann B, et al. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection. Vaccine. 2015;33:3813-20 pubmed 出版商
  79. Chowdhury A, Hayes T, Bosinger S, Lawson B, Vanderford T, Schmitz J, et al. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques. J Virol. 2015;89:8677-86 pubmed 出版商
  80. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  81. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed 出版商
  82. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed 出版商
  83. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed 出版商
  84. Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M, et al. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection. Infect Immun. 2015;83:2185-96 pubmed 出版商
  85. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed 出版商
  86. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  87. Konadu K, Chu J, Huang M, Amancha P, Armstrong W, Powell M, et al. Association of Cytokines With Exosomes in the Plasma of HIV-1-Seropositive Individuals. J Infect Dis. 2015;211:1712-6 pubmed 出版商
  88. Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296-305 pubmed 出版商
  89. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  90. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed 出版商
  91. Luetke Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, et al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014;10:e1004441 pubmed 出版商
  92. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed 出版商
  93. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014;9:e106903 pubmed 出版商
  94. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed 出版商
  95. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed 出版商
  96. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  97. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed 出版商
  98. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed 出版商
  99. Hu N, Mora Jensen H, Theilgaard Monch K, Doornbos van der Meer B, Huitema M, Stegeman C, et al. Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS ONE. 2014;9:e99671 pubmed 出版商
  100. Headland S, Jones H, D Sa A, Perretti M, Norling L. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237 pubmed 出版商
  101. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed 出版商
  102. Rossi E, Chang C, Goldenberg D. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus. PLoS ONE. 2014;9:e98315 pubmed 出版商
  103. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed 出版商
  104. Riese S, Kuehne C, Tedder T, Hallmann R, Hohenester E, Buscher K. Heterotropic modulation of selectin affinity by allosteric antibodies affects leukocyte rolling. J Immunol. 2014;192:1862-9 pubmed 出版商
  105. Teirlinck A, McCall M, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, et al. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog. 2011;7:e1002389 pubmed 出版商
  106. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed 出版商
  107. Cernea S, Herold K. Monitoring of antigen-specific CD8 T cells in patients with type 1 diabetes treated with antiCD3 monoclonal antibodies. Clin Immunol. 2010;134:121-9 pubmed 出版商
  108. Prakobphol A, Genbacev O, Gormley M, Kapidzic M, Fisher S. A role for the L-selectin adhesion system in mediating cytotrophoblast emigration from the placenta. Dev Biol. 2006;298:107-17 pubmed
  109. Zdravkovic T, Genbacev O, Prakobphol A, Cvetkovic M, Schanz A, McMaster M, et al. Nicotine downregulates the l-selectin system that mediates cytotrophoblast emigration from cell columns and attachment to the uterine wall. Reprod Toxicol. 2006;22:69-76 pubmed
  110. Bratke K, Kuepper M, Bade B, Virchow J, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol. 2005;35:2608-16 pubmed
  111. Kemp T, Ludwig A, Earel J, Moore J, Vanoosten R, Moses B, et al. Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L. Blood. 2005;106:3474-82 pubmed
  112. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  113. Biancone L, Cantaluppi V, Duò D, Deregibus M, Torre C, Camussi G. Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol. 2004;173:5268-74 pubmed
  114. Tan P, Chan C, Xue S, Dong R, Ananthesayanan B, Manunta M, et al. Phenotypic and functional differences between human saphenous vein (HSVEC) and umbilical vein (HUVEC) endothelial cells. Atherosclerosis. 2004;173:171-83 pubmed
  115. Lester E, Babensee J. Proinflammatory phenotype of endothelial cells after coculture with biomaterial-treated blood cells. J Biomed Mater Res A. 2003;64:397-410 pubmed
  116. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  117. Greco N, Lee W, Kurtz J, Seetharaman S, Moroff G. Characterization of multiple CD34+ cell populations in cord blood. J Hematother Stem Cell Res. 2003;12:199-213 pubmed
  118. Ku C, Padilla J, Grose C, Butcher E, Arvin A. Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol. 2002;76:11425-33 pubmed
  119. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood. 2002;100:2562-71 pubmed
  120. Sharron M, Pohlmann S, Price K, Lolis E, Tsang M, Kirchhoff F, et al. Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes. Blood. 2000;96:41-9 pubmed
  121. Greenberg A, Kerr W, Hammer D. Relationship between selectin-mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood. 2000;95:478-86 pubmed
  122. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed